Level Four Advisory Services, LLC Horizon Therapeutics Public LTD CO Transaction History

Level Four Advisory Services, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $556,518 - $1.02 Million	8,920 New	8,920 $1.02 Million
Q2 2022 Aug 08, 2022	BUY	$79.4 - $116.36 $202,390 - $296,601	2,549 Added 29.32%	11,242 $897,000
Q1 2022 May 10, 2022	SELL	$86.42 - $109.81 $111,136 - $141,215	-1,286 Reduced 12.89%	8,693 $915,000
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $366,643 - $446,065	3,720 Added 59.43%	9,979 $1.08 Million
Q3 2021 Oct 12, 2021	BUY	$91.91 - $110.37 $23,069 - $27,702	251 Added 4.18%	6,259 $686,000

Q2 2021 Aug 09, 2021	BUY	$86.24 - $95.92 $46,742 - $51,988	542 Added 9.92%	6,008 $563,000
Q1 2021 May 10, 2021	BUY	$71.83 - $95.48 $168,585 - $224,091	2,347 Added 75.25%	5,466 $503,000
Q4 2020 Feb 10, 2021	BUY	$67.0 - $84.39 $208,973 - $263,212	3,119 New	3,119 $228,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Level Four Advisory Services, LLC with notifications on news.